158 related articles for article (PubMed ID: 7505605)
1. Differentiation of heterogeneous phenotypes in human osteoblast cultures in response to 1,25-dihydroxyvitamin D3.
Thavarajah M; Evans DB; Kanis JA
Bone; 1993; 14(5):763-7. PubMed ID: 7505605
[TBL] [Abstract][Full Text] [Related]
2. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
[TBL] [Abstract][Full Text] [Related]
3. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
[TBL] [Abstract][Full Text] [Related]
4. Effects of transforming growth factor beta (TGF beta) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells.
Ingram RT; Bonde SK; Riggs BL; Fitzpatrick LA
Differentiation; 1994 Jan; 55(2):153-63. PubMed ID: 8143932
[TBL] [Abstract][Full Text] [Related]
5. 1,25 dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin.
Siggelkow H; Schulz H; Kaesler S; Benzler K; Atkinson MJ; Hüfner M
Calcif Tissue Int; 1999 May; 64(5):414-21. PubMed ID: 10203418
[TBL] [Abstract][Full Text] [Related]
6. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro.
Beresford JN; Joyner CJ; Devlin C; Triffitt JT
Arch Oral Biol; 1994 Nov; 39(11):941-7. PubMed ID: 7695507
[TBL] [Abstract][Full Text] [Related]
7. Actions of calcipotriol (MC 903), a novel vitamin D3 analog, on human bone-derived cells: comparison with 1,25-dihydroxyvitamin D3.
Evans DB; Thavarajah M; Binderup L; Kanis JA
J Bone Miner Res; 1991 Dec; 6(12):1307-15. PubMed ID: 1792941
[TBL] [Abstract][Full Text] [Related]
8. 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells.
Kassem M; Mosekilde L; Eriksen EF
J Bone Miner Res; 1993 Dec; 8(12):1453-8. PubMed ID: 8304046
[TBL] [Abstract][Full Text] [Related]
9. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Spiess YH; Price PA; Deftos JL; Manolagas SC
Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of a novel vitamin D analogue MC-903 and 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity, osteocalcin and DNA synthesis by human osteoblastic cells in culture.
Marie PJ; Connes D; Hott M; Miravet L
Bone; 1990; 11(3):171-9. PubMed ID: 2390375
[TBL] [Abstract][Full Text] [Related]
11. Titanium surface roughness alters responsiveness of MG63 osteoblast-like cells to 1 alpha,25-(OH)2D3.
Boyan BD; Batzer R; Kieswetter K; Liu Y; Cochran DL; Szmuckler-Moncler S; Dean DD; Schwartz Z
J Biomed Mater Res; 1998 Jan; 39(1):77-85. PubMed ID: 9429099
[TBL] [Abstract][Full Text] [Related]
12. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
Chen TL; Hauschka PV; Cabrales S; Feldman D
Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
[TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
Sterck JG; Klein-Nulend J; Burger EH; Lips P
J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
[TBL] [Abstract][Full Text] [Related]
14. Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures.
Chenu C; Valentin-Opran A; Chavassieux P; Saez S; Meunier PJ; Delmas PD
Bone; 1990; 11(2):81-6. PubMed ID: 2357426
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors.
Long MW; Robinson JA; Ashcraft EA; Mann KG
J Clin Invest; 1995 Feb; 95(2):881-7. PubMed ID: 7860771
[TBL] [Abstract][Full Text] [Related]
17. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of 1,25-dihydroxyvitamin D3-induced stimulation of alkaline phosphatase in cultured osteoblast-like cells.
Manolagas SC; Spiess YH; Burton DW; Deftos LJ
Mol Cell Endocrinol; 1983 Nov; 33(1):27-36. PubMed ID: 6357897
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.
Koshihara Y; Hoshi K; Ishibashi H; Shiraki M
Calcif Tissue Int; 1996 Dec; 59(6):466-73. PubMed ID: 8939773
[TBL] [Abstract][Full Text] [Related]
20. Increased potency of 1,25-dihydroxyvitamin D3 on human osteoblast-like cells following structural side-chain modification.
Evans DB; Thavarajah M; Uskokovic MR; Kanis JA
Bone; 1990; 11(6):439-43. PubMed ID: 2078438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
